SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cardiome -- CRME
CRME 2.330-2.1%May 16 5:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: zeta1961 who wrote (121)1/17/2007 6:24:45 PM
From: tuck  Read Replies (1) of 285
 
>>Cardiome Pharma Corp. Announces Public Offering
Wednesday January 17, 5:12 pm ET
NASDAQ: CRME TSX: COM

VANCOUVER, Jan. 17 /PRNewswire-FirstCall/ - Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) announced today that it is offering 8,000,000 common shares in the United States and Canada pursuant to a preliminary prospectus supplement. The corporation will grant the underwriters an option to purchase up to an additional 1,200,000 common shares at the offering price during the period ending 30 days from the closing of the offering to cover over-allotments, if any.

Bear, Stearns & Co. Inc. is acting as book-running manager in this offering and CIBC World Markets Inc., Canaccord Adams Inc. and Leerink Swann & Company are acting as co-managers.<<

snip

Stock is down to $10.50 or so after hours (but current bid/ask is showing even lower: $10.10 X $10.30). I'm going to be tempted to add in some way -- currently am short some Jan 10 puts that looked like they'd expire worthless this Friday -- if it weakens any more.

Cheers, Tuck
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext